Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Am J Ther. 2014 May-Jun;21(3):174–183. doi: 10.1097/MJT.0b013e3182459c53

Table 1.

Demographics and case characteristics of acetaminophen toxicity reports that were excluded from full assessment.

Unable to Determine (n=11) Unlikely Related (n=15) Excluded (n=18)

Age
 < 2 years 8 (73%) 12 (80%) 10 (56%)
2 to < 4 years 1 (9%) 1 (7%) 4 (22%)
4 to < 6 years 2 (18%) 2 (13%) 4 (22%)

Gender
Male 3 (27%) 8 (53%) 11 (61%)
Female 5 (46%) 7 (47%) 7 (39%)
Not Reported 3 (27%) 0 (0%) 0 (0%)

Death
Fatal 3 (27%) 12 (80%) 0 (0%)
Non-Fatal 8 (73%) 3 (20%) 18 (100%)

Drug Administered by
Parent 5 (46%) 6 (40%) 8 (44%)
Other 3 (27%) 6 (40%) 5 (28%)
Self 0 (0%) 1 (7%) 4 (22%)
Healthcare Facility 1 (9%) 1 (7%) 0(0%)
Not Reported 2 (18%) 1 (7%) 1 (6%)

Exposure Site
Home 2 (18%) 3 (20%) 12 (67%)
Healthcare Facility 1 (9%) 1 (7%) 0 (0%)
Other Residence 0 (0%) 2 (13%) 0 (0%)
Not Reported 8 (73%) 9 (60%) 6 (33%)

Reason for Exclusion
No Hepatic Event N/A N/A 16 (89%)
Acute Overdose 2 (11%)

Alternative Causes
Underlying Illness/Condition 9 (60%)
Exposure to Non-APAP Product N/A 3 (20%) N/A
Inconsistent Clinical Course 2 (13%)
Asphyxia Due to Overlay 1 (7%)